OOIR: Observatory of International Research

Papers

(The H4-Index of Cephalalgia is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	122
A missing piece in the puzzle of chronic dizziness: Dysautonomia	121
Evidence-based guidelines for the pharmacological treatment of migraine	92
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	87
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	79
Persistent idiopathic facial pain: Integrating headache neurology insights into interdisciplinary guidelines	60
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	51
International Classification of Headache Disorders-4 – Work in Progress 1	50
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia	49
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy	49
Harassment in the headache field: a global web-based cross-sectional survey	45
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	45
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	44
Predictive value of preoperative white and gray matter microstructural alterations for microvascular decompression outcome in classical trigeminal neuralgia	43
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	42
Depression screening in migraine - A double-edged sword	41
IHC 2025 late-breaking abstracts	41
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	40
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	40
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review	40
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	38
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	38
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	37
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	36
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	36

History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	35
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	35
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	34
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	34
2025 Highlights in migraine prevention	31
An altered reward system characterizes chronic migraine with medication overuse headache	31
Systemic lupus erythematosus mimicking retinal migraine: a case report	31
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	31